ASMact: Study on Management of Bronchial Asthma
Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.
1 other identifier
observational
500
1 country
2
Brief Summary
Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2025
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2025
CompletedFirst Submitted
Initial submission to the registry
January 26, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
CompletedFebruary 17, 2026
February 1, 2026
7 months
January 26, 2026
February 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in the number of correctly reported diagnoses before and after intervention
Assessment of adherence to guideline-based diagnostic and therapeutic management of pediatric patients presenting with acute asthma exacerbations in the emergency department.
Pre-intervention and through study completion, an average of 9 months
Percentage of patients with correct timing, dosage, and method of drug administration before and after intervention
Pre-intervention and through study completion, an average of 9 months
Percentage of patients with correct follow-up at discharge
Pre-intervention and through study completion, an average of 9 months
Percentage of patients in whom additional drugs are used in refractory cases
Pre-intervention and through study completion, an average of 9 months
Percentage of patients with correct therapy at discharge
Pre-intervention and through study completion, an average of 9 months
Secondary Outcomes (1)
Incidence of acute asthma exacerbations
Pre-intervention and through study completion, an average of 9 months
Study Arms (2)
Pre-intervention cohort
Pediatric patients aged 6-17 years presenting to the emergency department with an acute asthma exacerbation during the pre-intervention period (October 2024-May 2025). Patients received standard care according to local clinical practice prior to the implementation of the structured educational intervention. Intervention: No intervention (standard of care)
Post-intervention cohort
Pediatric patients aged 6-17 years presenting to the emergency department with an acute asthma exacerbation during the post-intervention period (October 2025-May 2026), after the implementation of a structured educational intervention for emergency department staff. Intervention: Educational intervention (health care provider-directed)
Eligibility Criteria
The study population consists of pediatric patients aged 6 to 17 years presenting to the emergency departments of two Italian tertiary-care hospitals (AOU IRCCS Meyer Children's Hospital in Florence and Arcispedale S. Anna in Ferrara) with an acute asthma exacerbation. Eligible patients were identified through retrospective review of electronic medical records of all emergency department visits occurring during the predefined study periods. Patients were included if they received a discharge diagnosis consistent with acute asthma exacerbation or related conditions (e.g., bronchospasm, asthma attack, asthmatic bronchitis, wheezing).
You may qualify if:
- Age between 6 and 17 years
- Presentation to the emergency department with a diagnosis of acute asthma exacerbation
- Evaluation in the emergency department of one of the participating centers during the study periods
You may not qualify if:
- Age \< 6 years or \> 17 years
- Diagnosis other than acute asthma exacerbation
- Incomplete or missing clinical data
- Patients transferred from other hospitals already treated for the same episode
- history of allergy to any drugs used in the protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Arcispedale S. Anna
Ferrara, FE, 44124, Italy
Meyer Children's Hospital IRCCS, Firenze
Florence, 50134, Italy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 26, 2026
First Posted
February 17, 2026
Study Start
November 5, 2025
Primary Completion
May 31, 2026
Study Completion
June 30, 2026
Last Updated
February 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share